Determining Concentrations of Factors Viii, IX and Fibrinogen in Fresh Frozen Plasma: An Alternative to Improve Treatment of Hemorrhagic Diseases in a Developing Country
Journal Title: Haematology International Journal - Year 2017, Vol 1, Issue 2
Abstract
Fresh frozen plasma (FFP) remains the only treatment of bleeding events in some developing countries. But access to this blood derived-product could be difficult. Determined the concentrations of coagulation factors VIII, IX and fibrinogen used in Mali. We have determined prospectively the concentrations of these factors from October 2015 to February 2016 in the FFP bags produced and distributed by the National Blood Transfusion Center (NBTC) in Mali. The assays were performed in the laboratory of medical biology in Hôpital du Mali (Bamako, Mali) using a semi automaton BioSolea4. Mean volume of 342 analyzed blood bags was 249.5 ± 42.7 mL (range: 130 - 374.4). Mean concentration of factor VIII was 0.4 ± 0.4 IU/mL (0.02-3.56 IU/mL), of factor IX 0.3 ± 0.2 IU/mL (0.05-1.5 IU/mL) and of fibrinogen: 2.6 ± 0.8 g/L (0.2- 4.8 g/L). As expected, concentration of factor VIII of the O group donors was lower than in other blood groups (0.3±0.3 vs 0.4±0.5 IU/mL) (p=0.009). Similar results were obtained with rhesus positive blood bags donors compare to those from others blood groups (0.3±0.3 vs 0.4±0.4 IU/mL) (p = 0.001). 1.1. Conclusion: Concentrations of coagulation factors in the FFP bags produce by NBTC, are 1.6 fold lower for factor VIII, and 2.3 fold for factor IX than in other countries. We suggest that the production and distribution of cryoprecipitate could be improved for the effective management of bleeding events in resource-limited countries with no access to specific concentrate coagulation factor.
Authors and Affiliations
Yacouba Lazare DIALLO
Keywords
Related Articles
- EP ID EP291040
- DOI -
- Views 107
- Downloads 0
Long-lasting Responses to Immunomodulatory Drugs (IMIDs) in Combination with Dexamethasone in Multiple Myeloma; Identification of Exceptional Responders at any Treatment Line
1.1. Background: There is a growing interest in the study of patients that achieve exceptionally long-lasting remissions although suffering from incurable neoplastic disorders. This is the case for multiple myeloma (MM),...
Transfusion Support and Red Cell Alloimmunisation in Thalassemia Patients
Thalassemias are the most common mono genetic disease worldwide. It has high frequency extending from the Mediterranean basin through the Middle East (Iran), India and Southeast Asia. In India, the carrier rate of Beta T...
A Unique Case of Primary Hepatic CD30-Positive, CD15-Negative Classical Hodgkin’s Lymphoma Presenting as Fever of Unknown Origin and Acute Hepatic Failure
Hodgkin’s lymphoma is a B-cell lymphoproliferative neoplasm that commonly presents with lymphadenopathy and constitutional symptoms. Primary Hodgkin’s lymphoma of the liver without extrahepatic lymphadenopathy is rare, r...
Multiple Myeloma in Cameroon: Clinico-Biological Characteristics of Patients; an Experience from Douala General Hospital
1.1. Background: Multiple myeloma is the most common haematological malignancy among blacks. There is paucity of data on this subject in Africa in general and Cameroon in Cameroon. This study aims at describing initial c...
The Role of Uric Acid in Carbohydrate Metabolism among Hypertensive Individuals
The association between fasting blood glucose and insulin and serum uric acid levels in general population, as well as the positive association between serum uric acid levels and development of type 2 diabetes mellitus h...